COVID-19期间银屑病患者生物制剂使用情况的调查：单中心经验 - Suppr

Suppr

超能文献

A survey of psoriasis patients on biologics during COVID-19: a single centre experience.

作者信息

Burlando Martina, Carmisciano Luca, Cozzani Emanuele, Parodi Aurora

机构信息

Dermatology Unit, DissaL, Policlinico San Martino-IRCCS Hospital, Genoa, Italy.

Biostatistics Unit, DissaL, Policlinico San Martino-IRCCS Hospital, Genoa, Italy.

出版信息

J Dermatolog Treat. 2022 Feb;33(1):596. doi: 10.1080/09546634.2020.1770165. Epub 2020 May 25.

DOI:10.1080/09546634.2020.1770165

PMID:32406283

Abstract

摘要

相似文献

A survey of psoriasis patients on biologics during COVID-19: a single centre experience.COVID-19期间银屑病患者生物制剂使用情况的调查：单中心经验

J Dermatolog Treat. 2022 Feb;33(1):596. doi: 10.1080/09546634.2020.1770165. Epub 2020 May 25.

The impact of COVID-19 infection on patients with psoriasis treated with biologics: an Italian experience.新型冠状病毒肺炎感染对接受生物制剂治疗的银屑病患者的影响：意大利的经验。

Clin Exp Dermatol. 2022 Dec;47(12):2280-2282. doi: 10.1111/ced.15336. Epub 2022 Sep 19.

A survey of psoriasis patients on biologics during COVID-19: a high-epidemic area experience - Franche Comté, France.新冠疫情期间法国弗朗什-孔泰大区银屑病生物制剂治疗患者的调查

Eur J Dermatol. 2021 Feb 1;31(1):101-103. doi: 10.1684/ejd.2020.3960.

COVID-19 and psoriasis: biologic treatment and challenges.COVID-19 与银屑病：生物治疗及挑战

J Dermatolog Treat. 2022 Mar;33(2):699-703. doi: 10.1080/09546634.2020.1789051. Epub 2020 Jul 6.

Should biologics for psoriasis be interrupted in the era of COVID-19?在新冠疫情时代，银屑病生物制剂是否应中断使用？

J Am Acad Dermatol. 2020 May;82(5):1217-1218. doi: 10.1016/j.jaad.2020.03.031. Epub 2020 Mar 19.

Single-center survey of biologic use for inflammatory skin diseases during the coronavirus disease 2019 pandemic.2019 冠状病毒病大流行期间用于炎症性皮肤病的生物制剂的单中心调查。

J Dermatol. 2021 Dec;48(12):1907-1912. doi: 10.1111/1346-8138.16159. Epub 2021 Sep 21.

Clinical management of psoriasis patients during the COVID-19 pandemic.COVID-19 大流行期间银屑病患者的临床管理。

J Dermatolog Treat. 2022 Mar;33(2):1166-1167. doi: 10.1080/09546634.2020.1781045. Epub 2020 Jun 22.

Biologic Therapies, Psoriasis, and COVID-19: Our Experience at the Psoriasis Unit of the University of Naples Federico II.生物疗法、银屑病与新型冠状病毒肺炎：那不勒斯费德里科二世大学银屑病治疗中心的经验

Dermatology. 2021;237(1):13-14. doi: 10.1159/000513575. Epub 2020 Dec 9.

The prevalence of SARS-CoV-2 infection and the severity of the course of COVID-19 in patients with psoriasis treated with biologic therapy.生物制剂治疗的银屑病患者中 SARS-CoV-2 感染的流行率和 COVID-19 病程的严重程度。

J Dermatolog Treat. 2022 May;33(3):1581-1584. doi: 10.1080/09546634.2020.1861177. Epub 2020 Dec 22.

Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: a multicenter study in the Czech Republic.新冠疫情全国封锁期间接受生物制剂治疗的银屑病患者的依从性、安全担忧及焦虑：捷克共和国的一项多中心研究

J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e682-e684. doi: 10.1111/jdv.16771. Epub 2020 Jul 9.

引用本文的文献

Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries.新冠疫情对银屑病患者的认知与影响：来自德国PsoBest和CoronaBest注册研究的数据

Psoriasis (Auckl). 2024 May 14;14:29-38. doi: 10.2147/PTT.S451666. eCollection 2024.

A systematic review and meta-analysis of investigating the mutual impact of COVID-19 and psoriasis: Focusing on COVID-19 course in psoriasis and the opinion on biologics in this setting.一项关于探究2019冠状病毒病（COVID-19）与银屑病相互影响的系统评价和荟萃分析：聚焦银屑病患者的COVID-19病程及在此背景下对生物制剂的看法。

Immun Inflamm Dis. 2023 Nov;11(11):e1063. doi: 10.1002/iid3.1063.

Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.新冠疫情期间接受生物制剂治疗的银屑病和化脓性汗腺炎患者的皮肤表现

J Clin Med. 2021 Dec 13;10(24):5841. doi: 10.3390/jcm10245841.

Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts.免疫抑制生物制剂不会增加感染新冠病毒或后续死亡的风险：一项来自马萨诸塞州的回顾性匹配队列研究。

J Am Acad Dermatol. 2022 Jan;86(1):252-255. doi: 10.1016/j.jaad.2021.08.065. Epub 2021 Sep 10.

Tumor necrosis factor inhibitors are associated with a decreased risk of COVID-19-associated hospitalization in patients with psoriasis-A population-based cohort study.肿瘤坏死因子抑制剂可降低银屑病患者 COVID-19 相关住院风险：一项基于人群的队列研究。

Dermatol Ther. 2021 Jul;34(4):e15003. doi: 10.1111/dth.15003. Epub 2021 Jun 5.

Psoriasis care during the time of COVID-19: real-world data on changes in treatments and appointments from a German university hospital.新冠疫情期间的银屑病护理：来自德国一家大学附属医院的治疗和预约变化的真实世界数据。

Eur J Dermatol. 2021 Apr 1;31(2):183-191. doi: 10.1684/ejd.2021.4016.

Psoriasis Management During the COVID-19 Pandemic: Recommendations by SIG Psoriasis (IADVL Academy).2019冠状病毒病大流行期间的银屑病管理：银屑病特别兴趣小组（印度皮肤科、性病与麻风病学协会学会）的建议

Indian Dermatol Online J. 2021 Jan 16;12(1):58-65. doi: 10.4103/idoj.IDOJ_685_20. eCollection 2021 Jan-Feb.

Eur J Dermatol. 2021 Feb 1;31(1):101-103. doi: 10.1684/ejd.2020.3960.

National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.国家银屑病基金会 COVID-19 工作组关于大流行期间银屑病管理的指南：第 1 版。

J Am Acad Dermatol. 2020 Dec;83(6):1704-1716. doi: 10.1016/j.jaad.2020.09.001. Epub 2020 Sep 4.

Association of COVID-19 with skin diseases and relevant biologics: a cross-sectional study using nationwide claim data in South Korea.COVID-19 与皮肤病及相关生物制剂的关联：使用韩国全国理赔数据的横断面研究。

Br J Dermatol. 2021 Feb;184(2):296-303. doi: 10.1111/bjd.19507. Epub 2020 Oct 13.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验